Furthermore, VR tau‐PET‐negative AD patients showed similar levels of tau accumulation compared to tau‐PET‐positive AD patients in early‐ and late‐stage tau regions in ADNI but showed significantly less longitudinal tau accumulation in the Amsterdam‐based cohort. The gene discussed is MAPT; the disease is Alzheimer disease.